S47 The Establishment of "Evidence Based Medicine" for the Treatment of Cerebral Stroke —Bridging Basic and Clinical Sciences — S47-1 Neuronal mechanisms underlying improvement of cognitive impairment and depressive behaviors in novel therapeutics of Alzheimer’s disease S47-2 Functional analysis of ischemia-responsive gene, Ifrd1, in brain S47-3 Protective effects of cilostazol, an antiplatelet drug, on infarction and hemorrhagic transformation after ischemia S47-4 Novel ameliorating action on cerebral infarction-induced urination disorder of drugs possessing GIRK channel inhibiting action S47-5 Development of glucose intolerance and neuronal damage in cerebral ischemic stress S47-6 The analysis of mechanisms underlying blood-brain barrier dysfunction using a novel in vitro BBB model